ZS Pharma (ZSPH) Announces Pricing Of Initial Public Offering
6/18/2014 11:08:38 AM
COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, Inc., a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the pricing of its initial public offering of 5,944,444 shares of its common stock at a price to the public of $18.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on June 18, 2014 under the symbol “ZSPH”. In addition, ZS Pharma has granted the underwriters a 30-day option to purchase up to an additional 891,667 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on or about June 23, 2014, subject to customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by